<https://rdf.molmedb.upol.cz/reference/ref1345> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17413>,
		<https://rdf.molmedb.upol.cz/transporter/target39>,
		<https://identifiers.org/molmedb/MM00718>,
		<https://identifiers.org/molmedb/MM01549>,
		<https://rdf.molmedb.upol.cz/transporter/target105>;
	<http://purl.org/ontology/bibo/doi> "10.1124/dmd.111.041731"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target38>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "de Waart DR, van de Wetering K, Kunne C, Duijst S, Paulusma CC, Oude Elferink RP.: Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos, Volume 40 (3), 2012"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "22166395"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra31796> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1345> .
<https://rdf.molmedb.upol.cz/transporter/tra31813> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1345> .
<https://rdf.molmedb.upol.cz/transporter/tra31740> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1345> .
<https://rdf.molmedb.upol.cz/transporter/tra31741> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1345> .
<https://rdf.molmedb.upol.cz/transporter/tra31739> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1345> .